| 36789415 | "Tumor Treating Fields" delivered via electromagnetic induction have varied effects across glioma cell lines and electric field amplitudes. | bioRxiv | 2023 |
| 37750087 | Carrimycin, a first in-class anti-cancer agent, targets selenoprotein H to induce nucleolar oxidative stress and inhibit ribosome biogenesis. | Cancer Pathog Ther | 2023 |
| 37511490 | TP5: A Novel Therapeutic Approach Targeting Aberrant and Hyperactive CDK5/p25 for the Treatment of Colorectal Carcinoma. | Int J Mol Sci | 2023 |
| 37936697 | Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy. | Front Immunol | 2023 |
| 37453673 | A novel HIF2A mutation causes dyslipidemia and promotes hepatic lipid accumulation. | Pharmacol Res | 2023 |
| 37018064 | Proteostasis Modulation in Germline Missense von Hippel Lindau Disease. | Clin Cancer Res | 2023 |
| 37450881 | Pacak-Zhuang syndrome: a model providing new insights into tumor syndromes. | Endocr Relat Cancer | 2023 |
| 37342258 | Intratumoral immunotherapy of murine pheochromocytoma shows no age-dependent differences in its efficacy. | Front Endocrinol (Lausanne) | 2023 |
| 37173979 | Epigenetic Regulation in Primary CNS Tumors: An Opportunity to Bridge Old and New WHO Classifications. | Cancers (Basel) | 2023 |
| 37339049 | A protocol for visualization of murine in situ neurovascular interfaces. | STAR Protoc | 2023 |
| 37434263 | rWTC-MBTA: autologous vaccine prevents metastases via antitumor immune responses. | J Exp Clin Cancer Res | 2023 |
| 37001383 | Lipin2 ameliorates diabetic encephalopathy via suppressing JNK/ERK-mediated NLRP3 inflammasome overactivation. | Int Immunopharmacol | 2023 |
| 37030115 | The combination of immunotherapy and a glutamine metabolism inhibitor represents an effective therapeutic strategy for advanced and metastatic murine pancreatic adenocarcinoma. | Int Immunopharmacol | 2023 |
| 36353857 | A 13-Year-Old Male With Left Eye Swelling. | Pediatrics | 2022 |
| 35489703 | Somatic Mosaicism of EPAS1 Mutations in Pacak-Zhuang Syndrome. | Endocr Pract | 2022 |
| 35387667 | Targeting selenoprotein H in the nucleolus suppresses tumors and metastases by Isovalerylspiramycin I. | J Exp Clin Cancer Res | 2022 |
| 35813464 | Isovalerylspiramycin I suppresses non-small cell lung carcinoma growth through ROS-mediated inhibition of PI3K/AKT signaling pathway. | Int J Biol Sci | 2022 |
| 36572976 | Acute worsening of CADASIL in a patient with COVID-19 infection: illustrative case. | J Neurosurg Case Lessons | 2022 |
| 36342229 | Targeting PP2A for cancer therapeutic modulation. | Cancer Biol Med | 2022 |
| 33049075 | C-Terminal, but Not Intact, FGF23 and EPO Are Strongly Correlatively Elevated in Patients With Gain-of-Function Mutations in HIF2A: Clinical Evidence for EPO Regulating FGF23. | J Bone Miner Res | 2021 |
| 33810617 | Mannan-BAM, TLR Ligands, Anti-CD40 Antibody (MBTA) Vaccine Immunotherapy: A Review of Current Evidence and Applications in Glioblastoma. | Int J Mol Sci | 2021 |
| 33776908 | Succinate Mediates Tumorigenic Effects <i>via</i> Succinate Receptor 1: Potential for New Targeted Treatment Strategies in Succinate Dehydrogenase Deficient Paragangliomas. | Front Endocrinol (Lausanne) | 2021 |
| 33497361 | Developmental vascular malformations in EPAS1 gain-of-function syndrome. | JCI Insight | 2021 |
| 33855601 | Mannan-BAM, TLR ligands, and anti-CD40 immunotherapy in established murine pancreatic adenocarcinoma: understanding therapeutic potentials and limitations. | Cancer Immunol Immunother | 2021 |
| 34945804 | Endogenous Retroviral Elements in Human Development and Central Nervous System Embryonal Tumors. | J Pers Med | 2021 |
| 34439097 | Identification of Immune Cell Infiltration in Murine Pheochromocytoma during Combined Mannan-BAM, TLR Ligand, and Anti-CD40 Antibody-Based Immunotherapy. | Cancers (Basel) | 2021 |
| 34638252 | Pharmacological Inhibition of PP2A Overcomes Nab-Paclitaxel Resistance by Downregulating MCL1 in Esophageal Squamous Cell Carcinoma (ESCC). | Cancers (Basel) | 2021 |
| 34546977 | Tentorial venous anatomy of mice and humans. | JCI Insight | 2021 |
| 34721537 | Down-Regulated CLDN10 Predicts Favorable Prognosis and Correlates With Immune Infiltration in Gastric Cancer. | Front Genet | 2021 |
| 34145313 | SMARCB1 deletion in atypical teratoid rhabdoid tumors results in human endogenous retrovirus K (HML-2) expression. | Sci Rep | 2021 |
| 34335453 | Multimodal Atlas of the Murine Inner Ear: From Embryo to Adult. | Front Neurol | 2021 |
| 32342332 | Inhibition of protein phosphatase-2A with LB-100 enhances antitumor immunity against glioblastoma. | J Neurooncol | 2020 |
| 33575476 | Metformin enhances anti-cancer effects of cisplatin in meningioma through AMPK-mTOR signaling pathways. | Mol Ther Oncolytics | 2020 |
| 33709018 | Induction of Immune Response Against Metastatic Tumors via Vaccination of Mannan-BAM, TLR Ligands and Anti-CD40 Antibody (MBTA). | Adv Ther (Weinh) | 2020 |
| 31876943 | Vascular Changes in the Retina and Choroid of Patients With EPAS1 Gain-of-Function Mutation Syndrome. | JAMA Ophthalmol | 2020 |
| 31876082 | Clinical manifestations of Pacak-Zhuang syndrome in a male pediatric patient. | Pediatr Blood Cancer | 2020 |
| 31935881 | Inhibition of PP2A with LB-100 Enhances Efficacy of CAR-T Cell Therapy Against Glioblastoma. | Cancers (Basel) | 2020 |
| 32011210 | Targeting PP2A inhibits the growth of triple-negative breast cancer cells. | Cell Cycle | 2020 |
| 33189686 | A Novel In Vitro Device to Deliver Induced Electromagnetic Fields to Cell and Tissue Cultures. | Biophys J | 2020 |
| 33101674 | Metabolic plasticity of IDH1<i>-mutant</i> glioma cell lines is responsible for low sensitivity to glutaminase inhibition. | Cancer Metab | 2020 |
| 32708903 | TP5, a Peptide Inhibitor of Aberrant and Hyperactive CDK5/p25: A Novel Therapeutic Approach against Glioblastoma. | Cancers (Basel) | 2020 |
| 32337341 | Neuraxial dysraphism in <i>EPAS1-</i>associated syndrome due to improper mesenchymal transition. | Neurol Genet | 2020 |
| 32274306 | Switching from Fatty Acid Oxidation to Glycolysis Improves the Outcome of Acute-On-Chronic Liver Failure. | Adv Sci (Weinh) | 2020 |
| 32235007 | A novel germline gain-of-function HIF2A mutation in hepatocellular carcinoma with polycythemia. | Aging (Albany NY) | 2020 |
| 32462735 | Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas. | J Pathol | 2020 |
| 32427851 | Somatic SF3B1 hotspot mutation in prolactinomas. | Nat Commun | 2020 |
| 30530185 | CHCHD10 is involved in the development of Parkinson's disease caused by CHCHD2 loss-of-function mutation p.T61I. | Neurobiol Aging | 2019 |
| 31648104 | Blocking lncRNA MALAT1/miR-199a/ZHX1 Axis Inhibits Glioblastoma Proliferation and Progression. | Mol Ther Nucleic Acids | 2019 |
| 31739997 | Coley's immunotherapy revived: Innate immunity as a link in priming cancer cells for an attack by adaptive immunity. | Semin Oncol | 2019 |
| 31185588 | Chiari Malformation Type 1 in <i>EPAS1</i>-Associated Syndrome. | Int J Mol Sci | 2019 |